Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001137439-25-000228·Dauntless Investment Group, LLC
Schedule 13G ownership disclosure
OKYO PHARMA LTD
Common · CUSIP: G6724L116
Event date: 2025-03-12
- Filing-level shares
- 1,999,380.00
- Percent of class
- 5.9%
- Dauntless Investment Group, LLC
Shares: 1,999,380.00 · Class: 5.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137439-25-000228
- Form type
- SCHEDULE 13G
- Filer
- Dauntless Investment Group, LLC
- CIK
- CIK 2044285
- Filed
- Mar 18, 2025
- Reporting period
- Mar 12, 2025
- Description
- Schedule 13G beneficial ownership